Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 12/20 | 0.37 |
| ▸ | ALPL | P05186 | 5/20 | 0.34 |
| ▸ | GRM5 | P41594 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19041889 | 0.77 | MAP4K1 (0.39) | MAP4K1GRM5ALDH1A1GAAMAPT | |
| SCHEMBL3231929 | 0.76 | — | — | |
| SCHEMBL19707192 | 0.75 | GRM1 (0.34) | ALDH1A1HSD17B10 | |
| SCHEMBL30199232 | 0.75 | GRM1 (0.34) | ALDH1A1HSD17B10 | |
| SCHEMBL19692901 | 0.74 | USP9X (0.42) | ALDH1A1HSD17B10 | |
| SCHEMBL24723495 | 0.72 | MAP4K1 (0.38) | MAP4K1GRM5ALDH1A1GAAMAPT | |
| SCHEMBL17630687 | 0.72 | MAP4K1 (0.38) | MAP4K1GRM5ALDH1A1GAAMAPT | |
| SCHEMBL34470940 | 0.72 | MAP4K1 (0.38) | MAP4K1ALPLGRM5ALDH1A1GAA | |
| SCHEMBL752154 | 0.72 | MAP4K1 (0.38) | MAP4K1GRM5ALDH1A1GAAMAPT | |
| SCHEMBL1191469 | 0.72 | ALDH1A1 (0.50) | MAP4K1GRM5ALDH1A1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109563103-B | Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto | 艾尼纳制药公司 | 2022-05-27 | — | — | CN | disclosed |